Johnson & Johnson (JNJ)

128.62
0.58 0.45
NYSE : Health Technology
Prev Close 128.04
Open 127.71
Day Low/High 127.46 / 128.97
52 Wk Low/High 118.62 / 148.99
Volume 984.77K
Avg Volume 9.34M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 346.94B
EPS 0.50
P/E Ratio 219.25
Div & Yield 3.60 (2.76%)

Latest News

Johnson & Johnson Announces Research Study With Apple Watch To Help Improve AFib Outcomes Including Stroke Prevention

Johnson & Johnson Announces Research Study With Apple Watch To Help Improve AFib Outcomes Including Stroke Prevention

Johnson & Johnson to collaborate with Apple to assess impact of wearable technology on earlier detection of AFib, improved diagnosis and patient outcomes

Johnson & Johnson Completes Acquisition Of Ci:z Holdings Co., Ltd.

Johnson & Johnson Completes Acquisition Of Ci:z Holdings Co., Ltd.

Acquisition Expands J&J's Portfolio of Science-based Dermocosmetic Beauty Products

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Big pharma is shaping up to be a consolidating category in 2019.

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

One of pharma's biggest CEO's talks M&A action on the exchange.

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Do we have to run for the hills? Not necessarily.

Video: Jim's Daily Rundown for Monday

Jim recaps last week's informative trip to San Francisco and his interview with Tim Cook, and shares his thoughts on UnitedHealth Group ahead of Tuesday's earnings, Five Below's holiday sales numbers, Citigroup's earnings and much more!

ATTENTION JNJ EMPLOYEES: Zamansky LLC Investigates Possible ERISA Violations In The Johnson & Johnson Savings Plan

ATTENTION JNJ EMPLOYEES: Zamansky LLC Investigates Possible ERISA Violations In The Johnson & Johnson Savings Plan

Zamansky LLC investigates Johnson & Johnson Inc. (NYSE:JNJ) ("J&J" or the "Company") on behalf of its current and former employees for potential violations of the federal Employee Retirement Income Security Act ("ERISA") in the J&J Savings Plan (the...

Weekly Roundup

The Dow, S&P 500 and Nasdaq all finished higher this week.

A Johnson & Johnson Volatility Trade

A Johnson & Johnson Volatility Trade

JNJ's current pennant pattern creates the potential for a big move in the month of January.

Market Pushes Higher as Trade Talks Begin in Beijing

In the AAP portfolio, Five Below is greatly outperforming on Monday thanks to an upgrade to "Overweight" and a price target bump to $118.

Weekly Roundup

Markets kicked off 2019 with more days of volatility.

Sifting for Stocks That Held Up in Today's Market Carnage

It was a rough day for U.S. equity markets as the Dow plunged 660 points.

Boeing, Caterpillar Shares Slide Following Apple's Warning of Slower China Sales

Boeing, Caterpillar Shares Slide Following Apple's Warning of Slower China Sales

Boeing and Caterpillar slide in the wake of Apple's bombshell sales revision.

Analyzing Market Themes This New Year's Eve

We believe the potential of a trade deal has increased in recent weeks so we are hesitant to sell into its strength.

ATTENTION JNJ EMPLOYEES: Zamansky LLC Investigates Possible ERISA Violations In The Johnson & Johnson Retirement Savings Plan

ATTENTION JNJ EMPLOYEES: Zamansky LLC Investigates Possible ERISA Violations In The Johnson & Johnson Retirement Savings Plan

Zamansky LLC investigates Johnson & Johnson Inc. (NYSE:JNJ) ("J&J" or the "Company") on behalf of its current and former employees for potential violations of the federal Employee Retirement Income Security Act ("ERISA") in the J&J Retirement Savings Plan...

Weekly Roundup

Markets once again had a volatile week.

Are Algos Jumping on J&J Headlines?

Are Algos Jumping on J&J Headlines?

Are machines jumping on Johnson & Johnson's human risk headlines?

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Wed. 12/26/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Wed. 12/26/18)

Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.

Adding to Johnson & Johnson

It is important to keep in mind how JNJ is much, much more than the baby powder business.

Adding to Cisco and CVS Before the Bell

Now that we have plenty of capital to work with and the market has moved a leg lower, we will continue upgrading the portfolio and reallocating cash into a few stronger names.

Trimming Microsoft and Raytheon, Adding to Johnson & Johnson

The combination of these two sales will finance a buy in JNJ and increase our cash position.

Johnson & Johnson Stock May Take a While to Rebound From Talc Hit

Johnson & Johnson Stock May Take a While to Rebound From Talc Hit

Shares have fallen hard, despite the company's vehement scientific and legal defense.

TheStreet Quant Rating: B (Buy)